In addition to the established prognostic factors, such as pathological tumor-node-metastasis (pTNM) stage, carcinoembryonic antigen (CEA) levels, and treatment strategies, increasing attention has been directed toward additional variables that may refine the accuracy of postoperative prognosis assessment in RC patients. This evidence concerns the gene CEACAM5 and metastasis.